Pharmadule Modular Pharmaceutical and Biopharmaceutical Production Facilities

Pharmadule offers the fastest and most profitable way to implement a pharmaceutical or biopharmaceutical production facility. With close to 20 years’ experience and about 60 successful project implementations around the world, our knowledge of the industry is unmatched.

Among our customers are many of the world’s major pharmaceutical companies. Our staff are dedicated professionals with direct experience of the pharmaceutical industry. Between them, they have over 650 years’ experience in design, operations, development, project management, maintenance and validation.

Our areas of expertise are:

  • Biopharmaceuticals
  • Chemical API
  • Fill and finish with aseptic processing
  • Oral solid dosage

Our additional value services include:

  • Process design and engineering
  • Facility design and engineering
  • Project management
  • Commissioning and qualification (IQ and OQ)
  • Centralised documentation (from initial design to handover for the complete scope)

Pharmadule is committed to giving your business a competitive edge. Our extensive skills and experience ensure the project is a smooth, precision operation that delivers top-quality results – on time and to budget. We are with you from the start of your project until your facility is up and running.

COMPLETE PROJECT COORDINATION SOLUTIONS

Pharmadule focuses on the critical elements of a pharmaceutical plant. We coordinate all activities and take full responsibility the whole project, guaranteeing that your plant begins production on schedule. Process engineering, architectural design, civil construction, and commissioning and qualification are all developed and fully integrated in parallel with ground preparation and construction.

We understand that time-to-market is crucial to the success of a drug, and our whole process is geared to getting your plant into production faster. Speed gives important financial benefits: Pharmadule’s solutions enable you to generate income much earlier and move into new markets more quickly, saving 6-12 months on most projects.

Pharmadule’s fast project implementation also allows you to defer your decision until you’re truly ready. Your will still be able to get to market on time.

FASTEST DELIVERY IN THE PHARMACEUTICAL INDUSTRY

Pharmadule’s delivery and start-up times are the fastest in the industry. Schedules are compressed by running activities in parallel. Site preparations take place while the facility is being fabricated in Sweden. Part of the qualification procedure is performed in Sweden prior to delivery, which leads to shorter on-site validation and involves fewer people.

PREDICTABLE PRODUCTION METHODS

Pharmadule’s predictable methods enable us to guarantee the price and the date when your facility will be delivered. We work to a fixed price with a defined cash flow and schedule, assuring that your business requirements will be met.

EFFICIENT PROJECT MANAGEMENT

Working with Pharmadule means you deal with one partner, avoiding the hassle of coordinating numerous subcontractors, consultants and construction companies. This makes the whole project easier, more effective and more economical. Cost overruns, time delays and technical difficulties typically associated with traditional construction are minimised.

FLEXIBLE PHARMACEUTICAL FACILITIES

A Pharmadule facility can easily be expanded so you can keep the initial investment to a minimum and then grow with the demand. In the event of changing market or business conditions, the Pharmadule facility can also be relocated. Standardisation ensures that expansion or relocation proceeds quickly and effectively.

Modular fabrication minimises risks as the facilities are fabricated in a controlled workshop environment. Fabrication is standardised and rationalised in an assembly line manner. Pre-qualification testing and customer inspection of the facilities are completed before shipment to assure compliance to the agreed specifications. Final commissioning and qualification (IQ and OQ) are carried out after reassembly at the client’s site.

Our facilities comply with cGMP requirements and can be designed to meet Biological Safety Levels (BSL) and High Potency Containment (HPC) as required.

Working with Pharmadule means you deal with one partner. This makes the whole project easier, more effective and more economical.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Address
Pharmadule AB

DanviksCenter 28

SE

Nacka

13130

Other

Sweden

+46 8 587 420 00 +46 8 587 428 88 www.pharmadule.com www.pharmadule.com www.pharmadule.com

Pharmadule Images

Products and Services

Video

White Papers

Related Projects



Biolab’s Research and Development Centre, Mississauga



Brazilian pharmaceutical firm Biolab Farmacêutica has opened a new research and development (R&D) centre in Mississauga in the Greater Toronto Area (GTA) of Ontario, Canada.

2 January 2018

Fresenius Kabi’s Pharmaceutical Manufacturing Facility Expansion, Wilson, North Carolina



German pharmaceutical firm Fresenius Kabi is expanding its pharmaceutical manufacturing facility in Wilson, North Carolina.

13 December 2017

Merck Innovation Center, Darmstadt



Merck is building a new innovation centre at its global headquarters in Darmstadt as a part of its €1bn ($1.12bn) strategic initiative, ONE Global Headquarters.

1 January 2017

Oxford Pharmaceuticals’ Generic Drug Facility, Birmingham, Alabama



Start-up pharmaceutical company Oxford Pharmaceuticals broke ground for the construction of a generic drug manufacturing and distribution facility in Jefferson County, Birmingham, Alabama, US, in September 2015.

1 September 2016

Eli Lilly Biotech Pilot Plant, Indianapolis



In October 2006 Eli Lilly completed the first phase of its biotech facility expansion in Indianapolis, which was made re

29 November 2006

Merck Vaccine Plant, Durham, NC, USA



Merck's 272,000ft² vaccine production plant is located on a 262-acre site in Treyburn Corporate Park on the north s

17 July 2006

Eli Lilly Humalog Manufacturing Facility, Carolina



In April 2001 Eli Lilly announced it was constructing a new biotech bulk manufacturing facility in Carolina, Puerto Rico

14 April 2004

Merck Sharpe & Dohme Formulation Plant



Merck Sharpe & Dohme, known as MSD Technology Singapore Pte Ltd in Singapore, opened their newest manufacturing facility

20 October 2003

Baxter BioPharma Solutions Parenteral



Baxter BioPharma Solutions is a contract manufacturer of pre-filled syringes, vials and cartridges for the packaging of vaccines and drugs to treat chronic conditions such as rheumatoid arthritis and multiple sclerosis.

19 June 2003

AstraZeneca Pharmaceutical Manufacturing Plant, Wuxi, Shanghai, China



In early 2001, AstraZeneca inaugurated a pharmaceutical plant in the Wuxi region of northeastern China.

13 May 2001

Press Release

Regional Offices

Pharmadule AB

DanviksCenter 28

SE

Nacka

13130

Other

Sweden

+46 8 587 420 00 +46 8 587 428 88 www.pharmadule.com www.pharmadule.com www.pharmadule.com
Gothenburg Office - Pharmadule AB

Arendals Allé, ARX

PO Box 8744

SE - 402 75 Gothenburg

Other

Sweden

+46 8 587 420 00 +46 31 794 13 09 www.pharmadule.com
Europe - Pharmadule Regional Office

55 Route de Chéne

1208 Geneva

Other

Switzerland

+ 41 22 736 69 91 www.pharmadule.com
USA - Pharmadule, Inc.

500 Hills Drive, STE 120

NJ 07921

Bedminster

Other

United States of America

+1 908 470 1023 +1 908 470 1024 www.pharmadule.com

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.